0.0122USD
−1.07 MUSD
60.62 M
About Biocure Technology Inc.
Sector
Industry
CEO
Sang-Mok Lee
Website
Headquarters
Vancouver
Founded
2007
ISIN
CA09075T1075
FIGI
BBG00KTB9L58
Biocure Technology, Inc. engages in the development and commercialization of biosimilar products. Its also offers CAR-T Cell immunotherapy, hair growth treatment, and FMD vaccine products. The company was founded on August 24, 2007 and is headquartered in Vancouver, Canada.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of BICTF is 0.0700 USD — it has increased by 124.36% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Biocure Technology Inc. stocks are traded under the ticker BICTF.
BICTF stock is 55.43% volatile and has beta coefficient of −0.25. Check out the list of the most volatile stocks — is Biocure Technology Inc. there?
Yes, you can track Biocure Technology Inc. financials in yearly and quarterly reports right on TradingView.
BICTF net income for the last quarter is −83.30 K USD, while the quarter before that showed 1.98 M USD of net income which accounts for −104.21% change. Track more Biocure Technology Inc. financial stats to get the full picture.
Today Biocure Technology Inc. has the market capitalization of 1.02 M, it has decreased by 14.04% over the last week.
No, BICTF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, BICTF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Biocure Technology Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Biocure Technology Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Biocure Technology Inc. stock shows the buy signal. See more of Biocure Technology Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.